Publications by authors named "Paul Glue"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

190,151

Total Likes

4,861

Extended Reach

353,175

Social Features

37
E
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.
Colleen Loo, Nick Glozier, David Barton, Bernhard T Baune, Natalie T Mills, Paul Fitzgerald, Paul Glue, Shanthi Sarma, Veronica Galvez-Ortiz, Dusan Hadzi-Pavlovic

Br J Psychiatry· December 2023

Videos about Article: user user

2 1 34 8 3

View All Article and Social Media Activity
I
Investigating the feasibility and safety of transcranial infraslow gray noise stimulation as a potential treatment for generalized anxiety disorder.
Cindy van Sleeuwen, Divya Adhia, Paul Glue, Dirk De Ridder

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS study.
Mary Lou Chatterton, Johana Kevin Perez, Thao Thai, Jan Faller, Colleen K Loo, Paul Glue

J Affect Disord· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Relapsing Catatonia After Lorazepam Discontinuation: A Systematic Review of Published Case Reports.
Olivia Brown, Linda McLay, Paul Glue, Yoram Barak

J Acad Consult Liaison Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketamine for treatment-resistant post-traumatic stress disorder: double-blind active-controlled randomised crossover study.
Ben Beaglehole, Paul Glue, Shona Neehoff, Shabah Shadli, Neil McNaughton

BJPsych Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study.
Natalie T Mills, Stevan Nikolin, Nick Glozier, David Barton, Bernhard T Baune, Paul Glue

Br J Psychiatry· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infraslow Closed-Loop Brain Training for Anxiety and Depression (ISAD): A pilot randomised, sham-controlled trial in adult females with internalizing disorders.
Tyson M Perez, Divya B Adhia, Paul Glue, Jiaxu Zeng, Peter Dillingham

Cogn Affect Behav Neurosci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Baby Boomers hazardous drinkers as they age? An exploratory interRAI study.
Yoram Barak, Gil Rothschild-Eliasi, Paul Glue, Robin Turner

Australas Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional connectivity-targeted high-definition transcranial infraslow grey noise stimulation for chronic low back pain: protocol for a double-blinded, randomised, controlled clinical trial.
Divya Bharatkumar Adhia, Ramakrishnan Mani, John Reynolds, Paul Glue, Johnnie Potiki

BMJ Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review of the Effect of Psychedelic-Assisted Therapy on Attitudes Toward Death, Life, and Spirituality on Symptoms of Distress, Depression, and/or Anxiety in Patients with Life-Threatening Illness.
Thivya Turner, Paul Glue

Psychedelic Med (New Rochelle)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allopregnanolone Concentrations After Ascending Single Dose Administration of Progesterone to Healthy Volunteers.
Natalie J Hughes-Medlicott, Hoang Nguyen, Paul Glue, Yoram Barak

Hum Psychopharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder.
Ben Beaglehole, Paul Glue, Shona Neehoff, Shabah Shadli, Neil McNaughton

J Psychopharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug driving, sedation, reaction time and blood levels: a prescriber's approach to the Land Transport (Drug Driving) Amendment Act 2022.
Marleen van Oeveren, Paul Glue, Charlotte Mentzel

N Z Med J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How does depressive cognition develop? A state-dependent network model of predictive processing.
Nathaniel Hutchinson-Wong, Paul Glue, Divya Adhia, Dirk de Ridder

Psychol Rev· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontal localisation of a theory-based anxiety disorder biomarker - Goal conflict specific rhythmicity.
Shabah M Shadli, Bruce R Russell, Veema Lodhia, Ian J Kirk, Paul Glue

J Affect Disord· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study.
Ben Beaglehole, Paul Glue, Shona Neehoff, Shabah Shadli, Neil McNaughton

J Psychopharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A safety and feasibility randomized placebo controlled trial exploring electroencephalographic effective connectivity neurofeedback treatment for fibromyalgia.
Lucy Anderson, Dirk De Ridder, Paul Glue, Ramakrishnan Mani, Cindy van Sleeuwen

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The new Mental Health Act? A potentially wasted opportunity.
Paul Glue, Giles Newton-Howes, Jessie Lenagh-Glue, Armon Tamatea, Johnnie Potiki

N Z Med J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral docetaxel plus encequidar - a phase 1 clinical trial.
David Wang, Noelyn Hung, Tak Hung, Karen Eden, Wing-Kai Chan, Paul Glue

Cancer Chemother Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?
Shabah M Shadli, Carina J Donegan, Muhammad Ss Bin Mohd Fahmi, Bruce R Russell, Paul Glue

J Psychopharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression.
Paul Glue, Neil McNaughton,

J Psychopharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM.
Colleen Loo, Nick Glozier, David Barton, Bernhard T Baune, Natalie T Mills, Paul Glue

Br J Psychiatry· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial.
Paul Glue, Colleen Loo, Johnson Fam, Hsien-Yuan Lane, Allan H Young

Nat Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of changing criteria on improving interRAI assessment for elder abuse: analysis of a national dataset from Aotearoa New Zealand.
Robin Turner, Paul Glue, Yoram Barak

BMJ Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.
Chiranth Bhagavan, Paul Glue, Will Evans, Lisa Reynolds, Thivya Turner

Trials· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical Study.
David Wang, Natalie Hughes-Medlicott, Lilian Klingler, Yi Wang, Noelyn Hung, Paul Glue

Pharmaceutics· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis